共 50 条
- [24] Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan JOURNAL OF CROHNS & COLITIS, 2022, 16 : I439 - I441
- [26] Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan JOURNAL OF CROHNS & COLITIS, 2022, 16 : I439 - I441